Acupuncture for Diabetic Peripheral Neuropathy: Meta-Analysis Shows Reduction in Sensory Symptoms and Improvement in Nerve Conduction Velocity

Diabetic peripheral neuropathy (DPN) affects between 30% and 50% of patients with long-standing diabetes mellitus, characterized by a “glove and stocking” pattern: paresthesia, burning, lancinating pain, distal hypesthesia, and, in advanced presentations, neuropathic ulceration. First-line pharmacologic treatment — gabapentinoids, tricyclic antidepressants, and dual SNRIs (duloxetine, venlafaxine) — offers partial relief in some patients, but with relevant adverse effects (sedation, weight gain, dizziness, dry mouth) that limit adherence. This scenario motivated the systematic investigation of acupuncture as adjuvant therapy.

What Recent Meta-Analyses Show

Systematic reviews published between 2022 and 2024 pooled randomized clinical trials majority conducted in China, with treatment for 4 to 12 weeks, in patients with mild to moderate diabetic peripheral neuropathy. The convergent findings indicate: clinically significant reduction on neuropathic pain scales; improvement on TCSS, the validated scale for neuropathy severity; increase in motor and sensory nerve conduction velocity (sural, peroneal, and tibial nerves); and improvement in associated symptoms — paresthesia, allodynia, sleep quality, and sexual function.

Plausible Mechanisms

Animal models and translational studies suggest multiple mechanisms: increased distal microcirculation — relevant in DPN, with an ischemic component; modulation of neurotrophic factors such as NGF, BDNF, and VEGF; reduction of oxidative stress markers and advanced glycation end products (AGEs); and activation of central analgesic pathways via endogenous opioids. In imaging studies, stimulation of points such as ST-36 and SP-6 modulates central áreas of neuropathic pain processing, including the periaqueductal gray and the anterior cingulate córtex.

Specific Cautions in the Diabetic Patient

The application of acupuncture in diabetic patients requires additional cautions: strict antiseptic rigor (greater risk of soft tissue infection in poorly controlled diabetes), avoid points in áreas of advanced hypesthesia — where the patient may not perceive local discomfort — and attention to patients on anticoagulants. Glycemia should be reasonably controlled before initiation, and integration with the endocrinologist is an essential part of the care plan.